GENFF (Genflow Biosciences) Research & Development: $1.50 Mil (TTM As of Dec. 2025)


What is Genflow Biosciences Research & Development?

Genflow Biosciences GENFF Research & Development is $1.50 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Genflow Biosciences's Research & Development for the six months ended in Dec. 2025 was $0.60 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $1.50 Mil.

Genflow Biosciences  (OTCPK:GENFF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genflow Biosciences Research & Development Related Terms

Genflow Biosciences Research & Development Historical Data

* Premium members only.

The historical data trend for Genflow Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genflow Biosciences Research & Development Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.11 0.88 1.51 1.46 1.49

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 1.19 0.27 0.90 0.60

Genflow Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.50 Mil mean?
Genflow Biosciences (GENFF) has a Research & Development of $1.50 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Genflow Biosciences and its competitors.
Is Genflow Biosciences' Research & Development too high?
Genflow Biosciences' current Research & Development is $1.50 Mil.
How does Genflow Biosciences' Research & Development compare to VRTX and REGN?
Genflow Biosciences' Research & Development of $1.50 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Genflow Biosciences and its competitors. Genflow Biosciences's current Research & Development is $1.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genflow Biosciences stock overvalued right now?
Genflow Biosciences (GENFF) has a current Research & Development of $1.50 Mil. The current Research & Development is $1.50 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Genflow Biosciences (GENFF), the current Research & Development is $1.50 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genflow Biosciences Business Description

Other Exchanges GENF:UKWQ5:Germany
Address 6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on the development of biological interventions (namely gene therapies) which are aimed at tackling the effects of aging, potentially slowing or halting the aging process and so reducing the incidence of age-related diseases and thereby increasing health span. Its flagship compound, GF-1002, is based on the delivery of a variant of the SIRT6 gene and is currently in preclinical development.